LRRK2 and Parkinson disease: An increase in nitric oxide species was observed under vehicle conditions in mutant LRRK2 (G2019S) (p < 0.05) and highly sensitive sporadic PD lines (p < 0.01), yet levels were not exacerbated further by valinomycin treatment (Supp.